Articles

  • 2 weeks ago | synbiobeta.com | Kevin Mayer

    Just because a technology has a long history doesn’t mean it can’t be at the cutting edge. Consider cell-free protein synthesis.

  • Dec 6, 2024 | genengnews.com | Kevin Mayer

    Home Topics Cancer Killer T Cells Programmed for Tissue- and Tumor-Specific Targeting Cancer cell attacked by lymphocytes Credit: luismmolina / Getty Images/iStockphoto Cancer-killing T cells have been programmed to have two levels of specificity. First, the T cells have been equipped with a receptor sensitive to a protein that is found only in central nervous system (CNS) tissue.

  • Dec 4, 2024 | genengnews.com | Kevin Mayer

    Home Topics Translational Medicine Super-Resolution Microscopy More Than Pretty Pictures The ONI Nanoimager is a desktop, super-resolution, single-molecule imaging platform that can visualize and track individual molecules in complex systems such as nanoparticles, living cells, and tissues, and do so with 20 nm resolution. Also, the instrument can enable investigations with different technologies, including dSTORM, PALM, PAINT, and smFRET.

  • Dec 3, 2024 | genengnews.com | Kevin Mayer

    Home Topics Cancer Cancer Immunotherapy Could Turn Up the Heat on Cold Tumors by Suppressing... Credit: Them Leach / Science Photo Library / Getty Images Credit: Them Leach / Science Photo Library / Getty Images Not all cancers respond strongly—or at all—to immunotherapies.

  • Nov 26, 2024 | genengnews.com | Kevin Mayer

    Tumor cell deaths can benefit tumors. A paradox? Not at all. If, for example, a dying tumor cell undergoes necroptosis, it can release inflammatory factors that can enhance or diminish antitumor immunity. Consequently, the idea of relying on necroptosis, an inflammatory form of cell death, as an alternative or adjunct to apoptosis, a non-inflammatory form of cell death, needs to be pursued with all due caution.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →